These contain minerals, chlorine, bacteria, and other contaminants that degrade peptides and introduce infection risk
BPC-157 (Body Protection Compound-157) is a short 15-amino-acid synthetic peptide widely used in preclinical research to examine how tissues respond to experimentally induced stress or injury in controlled laboratory models
OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship
As we discussed in this review, the upregulation of EpCAM and c-Met takes place in many human carcinomas and is in close relation to the development and propagation of cancers
V., Agers, H., Jusko, W
Can I switch to oral vitamin B12 supplements from B-29 AQ PFS Injection